Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Tesamorelin and visceral fat: what the trials show The evidence base for tesamorelin's effect on visceral adipose tissue (VAT) is the most robust of any GH peptide in clinical use
Its approval means it has undergone Phase 3 clinical trials, FDA safety review, and ongoing post-market surveillance
Dosage and Administration Protocols Because there is no standard FDA label, dosages are tailored to the individual patient by a qualified healthcare professional
More significant results like enhanced lean muscle mass, reduced body fat, and elevated natural growth hormone (HGH) levels typically emerge gradually over three to six months
2006 Mar;91(3):799-805
US$ 20.50
US$ 25.55
US$ 28.60
US$ 21.30
US$ 20.27
US$ 26.87
US$ 21.65
US$ 20.31
US$ 24.37
